
Viggo Bang-Hansen
Partner
Oslo
Newsletter
Published:
In connection with the Listing Act discussed in our newsletter of 4 December 2024, the European Securities and Markets Authority (ESMA) was mandated to propose supplementary provisions on the duty of disclosure in connection with protracted processes. ESMA was also asked to propose a list of situations where there is a contrast between existing inside information and previously published information, and delayed disclosure is thus prevented. Following the consultation process, ESMA's final proposal for a Commission Regulation was published on 7 May 2025, and is briefly summarised below
The Listing Act is a regulatory package that amends the Prospectus Regulation, MiFIR, MiFID II and MAR, including the rules on disclosure in connection with a protracted process and delayed disclosure of inside information. The changes to the rules regarding disclosure in connection with a protracted process and delayed disclosure of inside information will enter into force in the EU from 5 June 2026. It remains to be seen whether the rules will come into force in Norway, as non-EU member, from the same date.
In Sweden, the rules will apply to companies listed on Nasdaq Stockholm, NGM Main Regulated, Nasdaq First North, Nordic MTF and Spotlight Stock Market. In Norway, the rules will apply to companies listed on the Oslo Stock Exchange, Euronext Expand and Euronext Growth.
According to the current version of MAR, in protracted processes, it is not only the final event of a process that can constitute inside information, but also intermediate steps in a protracted process, provided that such intermediate steps meet the conditions for inside information. Consequently, such intermediate steps must either be published immediately, or – more practically – be subject to delayed disclosure until the final event has occurred, provided that the conditions for such delayed disclosure are met.
The Listing Act introduces a new exception in MAR stating that in protracted processes only the final event must be disclosed. However, an assessment whether such intermediate steps constitute inside information is still required, and if so, the rules regarding insider lists, duty of confidentiality, prohibition on trading, etc. apply as before. Should leaks occur, the disclosure obligation will be triggered as usual. In other words, the amendments to MAR consists in a simplification for listed companies to no longer be required to assess whether the conditions for delayed disclosure in protracted processes are met and prepare a report on this.
ESMA's proposal contains a wide range of examples of protracted processes, as well as indications of the time at which the final event is deemed to have occurred, and the duty of disclosure thus is triggered (unless the conditions for delayed disclosure are met). Among these are:
Whether a relevant protracted process constitutes inside information must still be determined on a case-by-case basis. Events in a protracted processes may be covered by the exemption to disclose inside information even if they do not appear on ESMA's list – this must also be determined from case-by-case.
Under the current version of MAR, delayed disclosure of inside information requires that the following conditions are met: (i) the immediate disclosure is likely to prejudice the legitimate interest of the issuer, (ii) delay of disclosure is not likely to mislead the public, and (iii) the issuer is able to ensure the confidentiality of the information. The interpretation of the second condition has raised difficulties, as any delayed disclosure in principle entails misleading the public. The Listing Act removes this condition and replaces it with a condition that the inside information is not
"in contrast with the latest public announcement or other type of communication by the issuer [...] on the same matter to which the inside information refers".
ESMA proposes a non-exhaustive list of cases where relevant inside information is considered to be in contrast with previously disclosed information as mentioned. Among these are:
It is worth noting that on the issuer's financial viability (bullet point 2 above), ESMA assumes that the issuer's need for a capital increase may constitute inside information where disclosure cannot be postponed if contrasting information about the issuer's financial strength has previously been made public. Even though a share issue is a protracted process that will not have to be published until a decision has been made, cf. above, and the rules on delayed disclosure therefore do not apply, this does not appear to cover information about the issuer's need for a capital increase in cases as mentioned.